Benjamin Davies on Muck Rack

Benjamin Davies

Verified
United Kingdom
As seen in: Haymarket Media, Color Research & Application, Archives of Disease in Childhood, BMJ Open, Postgraduate Medical Journal, Taylor & Francis Online, Campaign (UK), Journal Inquirer, The Times Literary Supplement, European Urology, Urology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Benjamin

Contact Benjamin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

When the Platform Owns the Procedure: Intellectual Property Rights and Robotic Surgery

|
By Benjamin Davies Verified, David Canes, Quoc-Dien Trinh, Jay Simhan, Alexander Kutikov
| European Urology Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Hashimoto, D.A. ∙ Rosman, G. ∙ Rus, D. ... Artificial intelligence in surgery: promises and perils Ann Surg. 2018; 268:70-76 2. Maier-Hein, L. ∙ Vedula, S.S. ∙ Speidel, S. ... Surgical data science for next-generation interventions Nat Biomed Eng. 2017; 1:691-696 3. Mascagni, P. ∙ Alapatt, D. ∙ Urade, T. ...
Open in Who Shared Issue with article?

Secondary analysis of a James Lind Alliance priority setting partnership to facilitate knowledge translation in degenerative cervical myelopathy (DCM): insights from AO Spine RECODE-DCM

|
By Benjamin Davies Verified, Oliver Mowforth, Danyal Khan, Jamie Brannigan
| BMJ Open Verified
Factors contributing to KT gaps in DCM There are several proposed barriers to rapid dissemination of DCM knowledge: Terminology—First proposed in 2015,35 the umbrella term of DCM is still not universal.36 ‘CSM’ is the most commonly used term, but this has an inconsistent definition.36 The use of variable terminology may therefore impede KT.
Open in Who Shared View Duplicates (3) Issue with article?

Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial-study protocol

|
By Benjamin Davies Verified, Oliver Mowforth, Stefan Yordanov, Daniel Alvarez-Berdugo
| BMJ Open Verified
Methods Study design and objectives RECEDE-Myelopathy is a multicentre, double-blind, randomised, placebo-controlled trial assessing the efficacy of Ibudilast as an adjuvant treatment to decompressive surgery for DCM. Participants will be randomised to receive either 60–100 mg Ibudilast (interventional arm) or placebo (control arm) starting within 10 weeks prior to surgery and continuing for 24 weeks after surgery for a maximum of 34 weeks of treatment.
Open in Who Shared View Duplicates (2) Issue with article?
See all 26 licensed articles (33 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified